CLINICAL_TRIALS
trial_result
· 2013-10-30
Clinical Trial Update: A Phase 2 Study Of PF-00232798 In HIV Positive Patients [Phase 2]
Summary
Pfizer completed a Phase 2 trial of PF-00232798 in HIV-infected patients, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: HIV | Phase 2 | Status: COMPLETED | Results posted: 2013-10-30